Extrawell Pharmaceutical Holdings Ltd
00858
Company Profile
Business description
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. Its segments are the manufacturing segment engages in the development, manufacture and sales of pharmaceutical products; and the trading segment engages in the marketing and distribution of imported pharmaceutical products. It derives the majority of revenue from the Manufacturing segment. Its operations are located in the PRC and Hong Kong.
Contact
979 King’s Road
Suites 2206-08, 22nd Floor
FWD Tower, Taikoo Place
Quarry Bay
Hong Kong
HKGT: +852 28561918
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
158
Stocks News & Analysis
stocks
ASX share undervalued despite margin woes
Short term margin pressure yet shares remain undervalued on improved outlook.
stocks
A better way to predict long-term stock returns
A value-weighted version of the CAPE ratio corrects a structural flaw and delivers stronger forecasts of long-term stock returns.
stocks
Five star stock added to August best ideas list
Morningstar analysts hand pick this undervalued opportunity for their August global best ideas.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,849.30 | 74.60 | -0.84% |
| CAC 40 | 8,098.99 | 18.79 | -0.23% |
| DAX 40 | 25,407.95 | 32.86 | -0.13% |
| Dow JONES (US) | 52,421.20 | 152.09 | -0.29% |
| FTSE 100 | 10,678.24 | 19.33 | -0.18% |
| HKSE | 24,667.24 | 250.36 | -1.00% |
| NASDAQ | 26,186.41 | 146.62 | -0.56% |
| Nikkei 225 | 63,484.10 | 8.89 | -0.01% |
| NZX 50 Index | 13,484.22 | 76.47 | -0.56% |
| S&P 500 | 7,619.98 | 37.00 | -0.48% |
| S&P/ASX 200 | 8,672.50 | 77.40 | -0.88% |
| SSE Composite Index | 3,864.28 | 21.05 | -0.54% |